Lower lipid peroxide levels in practitioners of the transcendental meditation® program

Psychosomatic Medicine

Volumn 60, Issue 1, 1998, Pages 38-41

  Schneider, Robert H ^a   Nidich, Sanford I ^b   Salerno, John W ^a   Sharma, Hari M ^c   Robinson, Charles E ^a,d   Nidich, Randi J ^b   Alexander, Charles N ^a  

^a MAHARISHI UNIVERSITY OF MANAGEMENT   (United States)

^b Maharishi Vedic University   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d HINES VA HOSPITAL   (United States)

Author keywords

Lipid peroxides; Oxidative stress; Transcendental Meditation

Indexed keywords

ANTIOXIDANT; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VITAMIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEAT; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; TRANSCENDENTAL MEDITATION;

EID: 0031893312     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199801000-00008     Document Type: Article

References (45)

1. Harman D: The aging process: Major risk factor for disease and death. Proc Natl Acad Sci USA, 88:5360-5363, 1991
2. Berliner J, Navab M, Fogelman A, et al: Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics. Circulation 91:2488-2496, 1995
3. Sohal R, Weindruch R: Oxidative stress, caloric restriction and aging. Science 273:59-63, 1996
4. Steinberg D, Parthasarathy S, Carew T, et al: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
5. Witztum JL: The oxidation hypothesis of atherosclerosis. Lancet 344:793-795, 1994
6. Naito C, Kawamura M, Yamamoto Y: Lipid peroxides as the initiating factor of atherosclerosis. Ann NY Acad Sci 27-45, 1990
7. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al: Low-density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86:1372-1376, 1989
8. Regnstrom J, Nilsson J, Tornvall P, et al: Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186, 1992
9. Salonen JT, Yla-Herttuala S, Yamamoto R, et al: Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339:883-887, 1992
10. Scarpellini F, Sbracia M, Scarpellini L: Psychological stress and lipoperoxidation in miscarriage. Ann NY Acad Sci 709:210-213, 1994
11. Santos TM, Valles J, Aznar J: Plasma lipid peroxides in patients with vascular disease and in middle-aged normal subjects with a high risk of atherosclerosis. CRC Handbook of Free Radicals and Antioxidants in Biomedicine, Vol. 1. 1988, 237-254
12. Adachi S, Kawamura K, Takemoto K: Oxidative damage of nuclear DNA in liver of rats exposed to psychological stress. Cancer Res 53:4153-4155, 1993
13. Alexander CN, Rainforth MY, Gelderloos P: Transcendental Meditation, self-actualization and psychological health: A conceptual overview and statistical meta-analysis. J Soc Behav Pers 6:189-247, 1991
14. Eppley K, Abrams AI, Shear J: Differential effects of relaxation techniques on trait anxiety: A meta-analysis. J Clin Psychol 45:957-974, 1989
15. Alexander CN, Robinson P, Orme-Johnson DW, et al: Effects of Transcendental Meditation compared to other methods of relaxation and meditation in reducing risk factors, morbidity and mortality. Homeostasis 35:243-264, 1994
16. Orme-Johnson DW: Medical care utilization and the Transcendental Meditation program. Psychosom Med 49:493-507, 1987
17. Barnes VA, Schneider RH, Alexander CN, et al: Randomized trial of stress reduction in older African American hypertensives: 5 year follow-up on all-cause and CVD mortality. Presented at the Eleventh Interdisciplinary Conference, International Society on Hypertension in Blacks. July 1996, New Orleans, LA
18. Alexander CN, Barnes VA, Schneider RH, et al: A randomized controlled trial of stress reduction on cardiovascular and all-cause mortality in the elderly: Results of 8 and 15 year follow-ups[Abstract]. Circulation 93:P19, 1996
19. Zamarra JW, Schneider RH, Besseghini I, et al: Usefulness of the Transcendental Meditation program in the treatment of patients with coronary artery disease. Am J Cardiol 78:77-80, 1996
20. Alexander CN, Langer EJ, Newman RI, et al: Transcendental Meditation, mindfulness, and longevity: An experimental study with the elderly. J Pers Soc Psychol 57:950-964, 1989
21. Wallace RK, Dillbeck M, Jacobe E, et al: The effects of the Transcendental Meditation and TM-Sidhi program on the aging process. Int J Neurol 16:53-58, 1982
22. Schneider RH, Alexander CN, Salerno JW, et al: Disease Prevention and Health Promotion in the Aging: A review of modern approaches and the Maharishi Vedic approach to health. J Alternative Complementary Med (in press)
23. Yagi K: Assay for serum lipid peroxide level and its clinical significance. In Yagi K (ed), Lipid Peroxides in Biology and Medicine. New York, Academic Press, 1982, 295-303
24. Riemersma RA: Epidemiology and the role of antioxidants in preventing coronary heart disease: A brief overview. Proc Nutr Soc 53:59-65, 1994
25. Stringer MD, Gorog PG, Freeman A, et al: Lipid peroxides and atherosclerosis. Br Med J 298:281-284, 1989
26. Hochschild R: Can an index of aging be constructed for evaluating treatments to retard aging rates? A 2,462-person study. J Gerontol 45:B187-214, 1990
27. Cohen, J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ, Hove and London, 1988
28. Anzar J, Santos MT, Valles J, et al: Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction. J Clin Pathol 36:712, 1983
29. Orme-Johnson DW: Autonomic stability and Transcendental Meditation. Psychosom Med 35:341-349, 1973
30. Jevning R, Wallace RK, Beldebach M: The physiology of meditation: A review. A wakeful hypometabolic integrated response. Neuro Biobehav Rev 16 :415-424, 1992
31. Mills PJ, Schneider RH, Hill D, et al: Lymphocyte beta-adrenergic receptors and cardiovascular responsivity in TM participants and Type A behavior. Psychosom Med 49:211, 1987
32. Mest HJ, Zehl V, Sziegoleit W, et al: Influence of mental stress on plasma levels of prostaglandins, thromboxane B2 and on circulating platelet aggregates in man. Prostaglandins Leukot Essent Fatty Acids 8:553, 1982
33. Robak J, Sobansk B: Relationship between lipid peroxidation and prostaglandin generation in rabbit tissues. Biochem Pharmacol 25:2233, 1976
34. Shimizu T, Kondo K, Hayaishi O: The role of prostaglandin endoperoxides in the serum thiobarbituric acid reaction. Arch Biochem Biophys 206:271, 1981
35. Schauer JE, Schelin A, Hanson P, et al: Dehydroepiandrosterone and a beta agonist, energy transducers, alter antioxidant enzyme systems: Influence of chronic training and acute exercise in rats. Arch Biochem Biophys 283:503-511, 1990
36. Barrett-Connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 315:1519-1524, 1986
37. Herrington DM, Gordon GB: Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 16:862-870, 1990
38. Glaser JL, Brind JL, Vogelman JH, et al: Elevated serum dehydroepiandrosterone sulfate levels in practitioners of Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med 15:327-341, 1992
39. Schneider RS, Mills PM, Schramm W: Serum dehydroepiandrosterone sulfate (DHEAS) levels in Transcendental Meditation practitioners. Psychosom Med 51:256, 1989
40. MacLean CRK, Walton KG, Wenneberg SR, et al: Apparent serum dehydroepiandrosterone response to acute laboratory stress. Soc Neurol Abstr 19:169, 1993
41. Singh RB, Niaz MA, Agarwal P, et al: Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc 95:775-780, 1995
42. Lonergan ET (ed): Extending Life, Enhancing Life: A National Research Agenda on Aging. (Committee on a National Research Agenda on Aging, Division of Health Promotion and Disease Prevention.) Washington, DC, National Academy Press, 1991
43. Greenberg ER, Sporn MB: Antioxidant vitamins, cancer and cardiovascular disease. N Engl J Med 334:1189-1190, 1996
44. Alexander CN, Schneider R, Claybourne M, et al: A trial of stress reduction for hypertension in older African Americans. Part II: Sex and risk factor subgroup analysis. Hypertension 28:228-237, 1996
45. Schneider RH, Staggers F, Alexander C, et al: A randomized controlled trial of stress reduction for hypertension in older African Americans. Hypertension 26:820-827, 1995